Telemetry Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Telemetry Investments’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-33,000	Closed	-$489K	–	136
2018 Q4	$489K	Buy	+33,000	New	+$548K	0.31%	77
2015 Q3	–	Sell	-65,350	Closed	-$1.28M	–	159
2015 Q2	$1.28M	Buy	65,350 +13,459	+26%	+$298K	0.58%	42
2015 Q1	$1.13M	Buy	+51,891	New	+$1.22M	0.62%	36

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Telemetry Investments's RCKT Position: Q1 2019 in Review

Telemetry Investments sold out of Rocket Pharmaceuticals (RCKT) in Q1 2019, closing a stake of 33,000 shares — an estimated $489K sold.

Telemetry Investments first reported a position in RCKT in Q1 2015 and held it in 3 quarters. The position peaked at $1.28M in Q2 2015. 81 funds tracked by Wall St. Rank hold RCKT as of Q1 2019.

Telemetry Investments reported no remaining Rocket Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Telemetry Investments sold 33,000 Rocket Pharmaceuticals shares in Q1 2019, an estimated $489K.
Telemetry Investments first reported a position in Rocket Pharmaceuticals in Q1 2015 and held it in 3 quarters.
Telemetry Investments's Rocket Pharmaceuticals position peaked at $1.28M in Q2 2015.
81 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2019.

Based on Telemetry Investments's 13F filing for Q1 2019, filed 15 May 2019.